» Articles » PMID: 32145402

Traditional Chinese Medicine for COVID-19 Treatment

Overview
Journal Pharmacol Res
Publisher Elsevier
Specialty Pharmacology
Date 2020 Mar 8
PMID 32145402
Citations 303
Authors
Affiliations
Soon will be listed here.
Citing Articles

Herb-disease association prediction model based on network consistency projection.

Chen L, Zhang S, Zhou B Sci Rep. 2025; 15(1):3328.

PMID: 39865145 PMC: 11770172. DOI: 10.1038/s41598-025-87521-7.


Quercetin: A Flavonoid with Potential for Treating Acute Lung Injury.

Huang M, Liu X, Ren Y, Huang Q, Shi Y, Yuan P Drug Des Devel Ther. 2024; 18():5709-5728.

PMID: 39659949 PMC: 11630707. DOI: 10.2147/DDDT.S499037.


Decoding the mechanism of Qingjie formula in the prevention of COVID-19 based on network pharmacology and molecular docking.

Pan Y, Lin W, Huang Y, Pan J, Dong Y Heliyon. 2024; 10(20):e39167.

PMID: 39640673 PMC: 11620151. DOI: 10.1016/j.heliyon.2024.e39167.


Comparative clinical trial of Langenlianqiao oral liquid and Lianhuaqingwen capsule in the treatment of mild cases of coronavirus disease 2019 (COVID-19).

Yang Y, Li Q, Liu Y, Zhou M J Health Popul Nutr. 2024; 43(1):158.

PMID: 39396047 PMC: 11479534. DOI: 10.1186/s41043-024-00649-6.


The anti-COVID-19 drug nirmatrelvir crosses the blood‒brain barrier and exhibits herb-drug pharmacokinetic interactions with formulations.

Lee W, Kung Y, Sun C, Chang C, Peng W, Lin L Heliyon. 2024; 10(15):e34820.

PMID: 39170551 PMC: 11336326. DOI: 10.1016/j.heliyon.2024.e34820.


References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View